J. Vestbo (Manchester, United Kingdom), A. G. N. Agusti (Palma De Mallorca, Spain)
Disease severity in COPD patients
M. V. Lopez Varela, F. Gimenez, A. Tempone, K. Fagundez (Montevideo, Uruguay)
|   |
What are the consequences of chronic cough and expectoration for health status among patients with COPD?
J. B. Stroband, T. S. Lapperre, J. K. Sont, K. F. Rabe, H. A. M. Kerstjens, M. M. E. Gosman, N. H. T. ten Hacken, D. S. Postma, P. J. Sterk (Groningen & Leiden, The Netherlands)
| |
Functional predictors of clinical disability in chronic obstructive pulmonary disease
C. Lisboa, A. Leiva, G. Borzone, R. Pinochet, O. Diaz (Santiago, Chile)
| |
Baseline characteristics of the first 5,000 COPD patients enrolled in the TORCH survival study
P. M. A. Calverley, B. Celli, G. Ferguson, C. Jenkins, P. Jones, N. B. Pride, J. Vestbo, J. Anderson, R. Pauwels (Liverpool, London, Greenford, United Kingdom; Boston, Michigan, ; Sydney, Australia; Hvidovre, Denmark; Ghent, Belgium)
| |
Initial treatment and mortality in COPD
T. E. Delea, R. H. Stanford, M. Hagiwara, J. S. Edelsberg, G. Oster (Brookline, Research Triangle Park, United States Of America)
| |
Relation of various parameters to the survival rate in stage 0 to stage IIa chronic obstructive pulmonary disease (COPD) according to the GOLD guidelines
R. Wakabayashi, H. Katsura, K. Yamada, T. Motegi, M. Omata, N. Nishimura, R. Goto, K. Kida (Tokyo, Japan)
| |
Survival quotient: an improved method for expressing severity of lung function abnormality
M. R. Miller, O. F. Pedersen, J. Lloyd, S. Hill, A. Dirksen (Birmingham, Sutton Coldfield, United Kingdom; Aarhus, Copenhagen, Denmark)
| |
Prevalence of comorbidity in patients with COPD and its effect on mortality
A. Cilli, C. Ozkaynak, A. Uslu, T. Ozdemir, C. Ogus (Antalya, Turkey)
| |